Welcome to HCPLive’s 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 healthcare headlines for February 09 – 16, 2025:
- FDA Accepts Lerodalcibep BLA for LDL-C Reduction in High-Risk Patients
Announced by LIB Therapeutics Inc., the agency has set a PDUFA target action date of December 12, 2025. - Travere Therapeutics Plans FSGS Submission for Sparsentan
An approval for sparsentan in focal segmental glomerulosclerosis would mark the second rare kidney disease approval for the agent. - Bimekizumab Long-Term Hidradenitis Suppurativa…